KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Net Cash Flow (2016 - 2025)

Humana (HUM) has disclosed Net Cash Flow for 16 consecutive years, with -$1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow changed N/A to -$1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a N/A change, with the full-year FY2025 number at $2.0 billion, up 180.02% from a year prior.
  • Net Cash Flow was -$1.2 billion for Q4 2025 at Humana, down from $1.3 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $8.7 billion in Q1 2023 to a low of -$8.5 billion in Q4 2022.
  • A 4-year average of $849.3 million and a median of $356.0 million in 2022 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 800.43% in 2022; the steepest drop was 833.74% in 2022.
  • Humana's Net Cash Flow stood at -$910.0 million in 2021, then plummeted by 833.74% to -$8.5 billion in 2022, then surged by 202.08% to $8.7 billion in 2023, then crashed by 113.7% to -$1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Net Cash Flow are -$1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and -$210.0 million (Q2 2025).